
Vanguards of Healthcare by Bloomberg Intelligence
Vanguards of Healthcare is a series of exclusive conversations with management teams and thought leaders discussing changes on the forefront of the industry, including innovations in medical products and technologies, advances in clinical research, new service models, wellness and regulations.
Biolinq Introduces New Microsensor Tech For Next Chapter of Glucose and Analyte Detection
“I think we should do everything possible to lower the barriers for everybody to learn about glucose and metabolism,” Biolinq CEO Rich Yang tells Bloomberg Intelligence. In this Vanguards of Healthcare podcast episode, Yang sits down with BI analyst Matt Henriksson for an in-depth interview about B…
40:57
Akido Bets AI Can Break Healthcare’s Scarcity Problem
“In five years in healthcare, every single person in America will have the same kind of quality of healthcare that Jeff Bezos has.” Akido Labs co-founder and CEO Prashant Samant joins Bloomberg Intelligence analyst Jonathan Palmer to explain why AI could turn concierge medicine from a luxury into a…
45:06
Happy Health Develops a Wearable that Can Drive Healthcare Decision Making
“We wanted to be kind of the catalyst of collision between these two worlds, bringing wearable devices with all of their simplicity and the delightfulness of the experience with medical devices, with their accuracy and their ability to actually drive better health outcomes,” Happy Health co-founder…
50:34
Field Medical Develops New PFA Tech to Treat More Patients
“We don’t have any purpose-built technologies for the treatment of VT (ventricular tachycardia), and when I had a chance to look at what Field was building and the opportunity here to build out a new space and a new sector, it was very exciting to me,” Field Medical CEO Mark Turco explains regardin…
54:20
Tandem Diabetes’ Pump Portfolio Has Rubber Hitting the Floor
“If you look at the tubeless market, you know, we're seeing growth rates in excess of 25% annually,” Tandem Diabetes CEO John Sheridan explains to Bloomberg Intelligence about the growth opportunities in insulin pumps. In this episode of Vanguards of Health Care, Sheridan sits down with BI analyst …
43:30
Cityblock Health Reimagines Care for Those Left Behind
“It’s not about the technology itself, it’s about the form factor,” says Dr. Toyin Ajayi, co-founder and CEO of Cityblock Health. She joins Bloomberg Intelligence analyst Jonathan Palmer to explain how the company is redesigning care for complex Medicaid and Medicare populations around medical, beh…
49:27
Natera’s Billion-Dollar R&D Bet on the Future of Cancer Testing
“Clinical data is the key to being successful in diagnostics,” Steve Chapman, CEO of Natera, tells Bloomberg Intelligence analyst Jonathan Palmer as he explains how an early bet on evidence helped turn a small genetic-testing company into a broad diagnostics platform. Chapman traces Signatera from …
50:01
Resmed’s Expanding Within Sleep Health
“I almost think of, you know, cardiovascular disease, diabetes, and these other areas as verticals. Sleep is a horizontal and it can impact all of the above,” Resmed CEO Mick Farrell explains to Bloomberg Intelligence. In this Vanguards of Healthcare episode, Farrell sits down with BI analyst Matt …
52:32
Datavant is Building the Data Layer AI Needs in Healthcare
“Only about 7% of healthcare data is available to the frontier models,” says Kyle Armbrester, CEO of Datavant. He joins Bloomberg Intelligence analyst Jonathan Palmer to discuss why healthcare’s AI opportunity starts with solving its fragmented-data problem. Armbrester explains Datavant’s role conn…
49:38
FocalTherics Incorporates Therapeutic Ultrasound Across an Expanding List of Pathologies
“HIFU (high intensity focal ultrasound) is very valuable as a therapeutic treatment, but histotripsy may have some added value. We can develop a platform that can do HIFU or histotripsy or combine the two on a single platform,” Focaltherics explains to Bloomberg Intelligence. In this Vanguards of H…
48:17